Cargando…

Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells

BACKGROUND: Gastric cancer (GC) has a poor prognosis and limited therapeutic options. As a new promising cancer therapeutic approach, chimeric antigen receptor (CAR)-T cells represent a potential GC treatment. We investigated the antitumor activity of CAR-T cells target-B7H3 in GC. METHODS: In our s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Fengqiang, Yu, Xiaomei, Ju, Ruixue, Wang, Zhanzhao, Wang, Yuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802437/ https://www.ncbi.nlm.nih.gov/pubmed/35101032 http://dx.doi.org/10.1186/s12935-022-02471-8

Ejemplares similares

Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes
por: Liu, Jie, et al.
Publicado: (2021)

Chimeric antigen receptor T (CAR-T) cells expanded with IL-7/IL-15 mediate superior antitumor effects
por: Zhou, Jianxia, et al.
Publicado: (2019)

Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
por: Wang, Yan, et al.
Publicado: (2023)

Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
por: Otáhal, Pavel, et al.
Publicado: (2015)

B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma
por: Wang, Yi, et al.
Publicado: (2023)

PSCA is a target of chimeric antigen receptor T cells in gastric cancer
por: Wu, Di, et al.
Publicado: (2020)

Administration of B7-H3 targeted chimeric antigen receptor-T cells induce regression of glioblastoma
por: Tang, Xin, et al.
Publicado: (2021)

LncRNA HCG11 promotes proliferation and migration in gastric cancer via targeting miR-1276/CTNNB1 and activating Wnt signaling pathway
por: Zhang, Hua, et al.
Publicado: (2019)

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
por: Nehama, Dean, et al.
Publicado: (2019)

Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma
por: Ogunnaike, Edikan A., et al.
Publicado: (2021)

Antitumor effects of the small molecule DMAMCL in neuroblastoma via suppressing aerobic glycolysis and targeting PFKL
por: Zhang, Simeng, et al.
Publicado: (2021)

Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer
por: Lv, Jiang, et al.
Publicado: (2019)

Bioactivity and safety of B7‐H3‐targeted chimeric antigen receptor T cells against anaplastic meningioma
por: Tang, Xin, et al.
Publicado: (2020)

Generation of Chimeric Antigen Receptors against Tetraspanin 7
por: Pieper, Tom, et al.
Publicado: (2023)

PADI3 plays an antitumor role via the Hsp90/CKS1 pathway in colon cancer
por: Chai, Zhengbin, et al.
Publicado: (2019)

Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
por: Ma, Yongchen, et al.
Publicado: (2018)

M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors
por: Huo, Yi, et al.
Publicado: (2023)

Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
por: Zhang, Yajun, et al.
Publicado: (2021)

miR-450b-3p inhibited the proliferation of gastric cancer via regulating KLF7
por: Yao, Juan, et al.
Publicado: (2020)

Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
por: Jung, Minkyu, et al.
Publicado: (2020)

B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway
por: Kang, Fu-biao, et al.
Publicado: (2015)

Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo
por: Yuan, Bo, et al.
Publicado: (2018)

Antitumoral potency of methanolic extract from Nitraria retusa leaves via its immunomodulatory effect
por: Boubaker, Jihed, et al.
Publicado: (2015)

Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
por: Tomida, Akimasa, et al.
Publicado: (2021)

Antitumor effect of lysine-isopeptides
por: Szende, B, et al.
Publicado: (2002)

Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
por: Han, Xiao, et al.
Publicado: (2019)

B7-H3 chimeric antigen receptor-modified T cell shows potential for targeted treatment of acute myeloid leukaemia
por: Fan, Shuangshuang, et al.
Publicado: (2023)

Clinical significance of serum soluble B7-H3 in patients with osteosarcoma
por: Wang, Ling, et al.
Publicado: (2018)

Engineering Chimeric Antigen Receptors
por: Kulemzin, S. V., et al.
Publicado: (2017)

MicroRNA-1269 promotes cell proliferation via the AKT signaling pathway by targeting RASSF9 in human gastric cancer
por: Liu, Wen-Li, et al.
Publicado: (2019)

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
por: Xiong, Wei, et al.
Publicado: (2018)

Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
por: Xiong, Wei, et al.
Publicado: (2021)

Generation of TIM3 inhibitory single-domain antibodies to boost the antitumor activity of chimeric antigen receptor T cells
por: Yang, Liu, et al.
Publicado: (2021)

lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p
por: Han, Shuyi, et al.
Publicado: (2021)

NEK7 promotes gastric cancer progression as a cell proliferation regulator
por: Li, Yi-Ke, et al.
Publicado: (2021)

The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment
por: Yang, Encheng, et al.
Publicado: (2016)

MicroRNA-4316 inhibits gastric cancer proliferation and migration via directly targeting VEGF-A
por: Mousa, Haithm, et al.
Publicado: (2020)

B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
por: Zi, Zhenguo, et al.
Publicado: (2020)

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
por: Shen, Chunyi, et al.
Publicado: (2021)

Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer
por: Dong, Xuhui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lqiets3tpuujl6rqru6d0e0d62